Is Spravato Addictive? What Patients Should Know [2025]
August 31, 2025
When traditional antidepressants fail to provide relief, Spravato offers new hope for treatment-resistant depression. Yet, many patients wonder about its addiction potential compared to other ketamine therapies – and rightfully so. You have the right to know if your treatment plan with Spravato / Esketamine will have any kind of side effects.
What you should know is that this FDA-approved nasal spray has been proven effective against depressive symptoms in clinical settings. Spravato is only administered under strict medical supervision in certified clinics like Marpa Minds, with comprehensive safety protocols that significantly reduce risks while maximizing therapeutic benefits.
Unlike off-label ketamine infusions, Spravato’s regulated approach ensures patient safety through supervised administration, minimized side effects, standardized dosing, and insurance coverage options.
If you’re still wondering, “Is Spravato addictive?” and want to know why the odds of addiction are minimal with this treatment, keep reading and find everything you need to know about this topic.
Key Takeaways
- Spravato is FDA-approved for treatment-resistant depression or major depressive disorder, offering a safer, insurance-covered alternative to ketamine infusions.
- Spravato works rapidly (hours/days) against depressive symptoms, by targeting glutamate receptors, unlike traditional antidepressants that take weeks to show effects.
- Low addiction risk in clinical settings due to supervised administration, monitoring, and strict REMS protocols.
- Relatively mild side effects in most situations (and manageable too, as the treatment happens under the supervision of a healthcare provider)
- Clinics implement seven safety measures, including screening, supervision, therapy support, and patient education, to minimize dependence risk.
- Marpa Minds offers Spravato in a spa-like environment, handling insurance plan approvals and administrative tasks so you can focus on healing.
What Is Spravato and How Does It Differ From Ketamine?
Spravato has a low addiction potential when used as prescribed under medical supervision. It’s considered safe for most patients when administered in a clinical setting.
Spravato is the FDA-approved nasal spray form of esketamine, designed specifically for adults with treatment-resistant depression. This means it’s for people whose depression hasn’t improved after trying at least two different antidepressants.
Understanding intranasal esketamine
Esketamine is a purified form of ketamine that you take as a nasal spray for depression, proven to be efficient in clinical studies. You can only receive it in certified treatment centers where medical staff can supervise you.
The nasal spray lets the medication absorb quickly through your nasal passages, which leads to rapid symptom relief (some of our patients even report their depressive symptoms getting milder hours after treatment).
At Marpa Minds, we use this FDA-approved system in our comfortable clinical environment to ensure you get the exact dose you need.
Key distinctions from ketamine infusions
Spravato and ketamine infusions differ in several important ways that affect your safety and insurance coverage:
| Aspect | Spravato (Esketamine) | Ketamine Infusions |
|---|---|---|
| FDA Approval | Yes, for depression | No, off-label use |
| How you take it | Nasal spray | IV drip |
| Where you get it | Certified clinics only | Various locations |
| Insurance | Often covered | Usually cash only |
| Dosing | Same for everyone | Varies by provider |
These differences matter because FDA approval means insurance companies recognize Spravato as a legitimate treatment. You’ll likely pay less out-of-pocket compared to ketamine infusions.
How Does Spravato Work for Severe Depression?
Spravato works differently from traditional antidepressants by blocking NMDA receptors in your brain. In contrast, other drugs like traditional antidepressants adjust chemicals like serotonin, which may or may not have effects on some people, depending on their symptoms and the severity of their depression.
Spravato targets the glutamate system instead, which is your brain’s main communication chemical. This creates new neural connections in your brain, helping you have a different outlook on life.
Wondering if Spravato can work for you? Read more on our blog:
- Does Spravato help with depression?
- Does Spravato help with anxiety?
- How long does Spravato last?
- What do you do during Spravato treatment?
- Can Spravato be taken at home?
- How does Spravato make you feel?
Targeting NMDA receptors
When Spravato blocks glutamate receptors (NMDA receptors), it increases glutamate activity in parts of your brain that control mood. This helps your brain grow new connections — like building new roads where the old ones were blocked.
Think of depression as creating roadblocks in your brain’s communication highways. Spravato helps build detours around these blocks so messages can flow freely again.
Why esketamine can offer rapid symptom relief
Unlike regular antidepressants that take 4-8 weeks to work (and may completely disappoint many patients), esketamine can improve symptoms within hours or days. This happens because it immediately affects how your brain cells communicate.
The quick response doesn’t work for everyone, but many patients at Marpa Minds notice improvements in mood or energy much sooner than with traditional medications.
Does Spravato Give Physical or Psychological Dependence?
Research shows Spravato has a low risk of addiction when used properly in clinical settings for the treatment of severe depression. Patients rarely report wanting more than their prescribed dose.
The controlled environment is key — you can’t take Spravato home, and medical staff supervise every dose, while mental health providers help with the integration therapy. This eliminates chances for misuse.
Comparing psychological vs physiological dependence
Understanding different types of dependence helps clarify why Spravato is considered safe:
- Physical dependence: Your body needs the drug to function normally
- Psychological dependence: You feel you need the drug emotionally
- Addiction: You keep using despite harmful consequences
Spravato doesn’t cause physical dependence like opioids do. Some patients might feel attached to feeling better, but that’s different from addiction.
Research findings on the low risk of misuse
Studies show most patients feel neutral about Spravato itself, which minimizes the abuse potential. They care about feeling better, not about the medication’s effects.
The supervised setting at facilities like Marpa Minds adds another layer of safety. Healthcare providers watch for any concerning patterns and adjust treatment if needed.
Myths and Facts About Esketamine Safety
Many misconceptions about Spravato come from confusion with recreational ketamine use. Let’s clear up the most common myths.
Myth 1: Spravato is too new
Spravato received FDA approval in 2019, but ketamine has been used safely in medicine since the 1960s. The FDA required extensive testing before approval.
Thousands of patients participated in clinical trials to prove Spravato’s safety and effectiveness for depression.
Myth 2: Spravato causes uncontrollable cravings
Research shows most patients don’t develop cravings when using Spravato as prescribed. The clinical setting prevents patterns that lead to substance abuse.
Patients at Marpa Minds focus on getting better, not on seeking the medication for its effects.
Fact 1: FDA approval ensures medical oversight
FDA approval means Spravato went through rigorous safety testing. Healthcare providers have clear guidelines for safe use.
This regulatory framework provides safety layers that don’t exist with off-label treatments. Moreover, it makes most insurance providers cover Spravato as part of their insurance plans, which helps patients when it comes to treatment costs.
Fact 2: Structured monitoring and REMS
REMS (Risk Evaluation and Mitigation Strategy) is a safety program that controls how Spravato is distributed. Only certified facilities can provide it.
You must be monitored for at least two hours after each dose. Every aspect of your treatment is carefully tracked.
7 Ways Clinics Reduce the Abuse Potential
Professional clinics use multiple safety measures to protect patients while maximizing treatment benefits. These protocols create a comprehensive safety net.
1. Thorough patient screening
Before starting treatment, your clinical team will review your complete medical history and any past substance use. This treatment protocol helps identify any factors that might increase risk.
Healthcare providers look at your psychiatric history and previous treatments to determine if Spravato is right for you.
2. Supervised administration
Every dose happens under medical supervision in a certified facility. You can’t take medication home.
The two-hour monitoring period ensures your safety and lets providers observe how you respond to treatment, which aligns with what to expect during Spravato treatment.
3. Integrated therapy support
With ketamine treatment, the long-term outcomes are improved when combined with ongoing therapy. This approach addresses psychological factors while the medication helps your brain chemistry.
Therapy helps you develop healthy coping strategies and process changes during treatment, so you can better fight depression symptoms in the long run. While the specific integration therapy differs from one patient to the next, various methods have been shown effective, from group therapy sessions to art therapy and meditation.
4. Careful dosing protocols
Clinics follow FDA-approved treatment protocols and dosing schedules that have been tested for safety. Providers can’t arbitrarily increase doses of intranasal esketamine.
This structured approach prevents the escalation patterns seen with addictive substances.
5. Follow-up and aftercare
Regular check-ins between sessions help track your progress. Providers watch for any concerning changes (including any kind of abuse potential).
Early intervention can address side effects or issues before they become serious problems.
6. Insurance and REMS coordination
Insurance authorization and REMS compliance create oversight that prevents inappropriate use. These systems track every dose.
For example, Marpa Minds handles the coordination with the insurance companies to reduce your burden while maintaining safety standards.
7. Transparent patient education
You’ll learn about treatment expectations, side effects, and why following protocols matters. Informed patients make safer choices.
Education includes understanding the difference between therapeutic use and recreational drug use.
Who Should Consider Spravato Therapy?
Spravato is specifically for adults with treatment-resistant depression who meet FDA criteria. Proper evaluation determines if you’re a candidate.
The ideal candidate has tried multiple traditional treatments without adequate relief. This shows that standard approaches haven’t been effective.
Treatment-resistant depression criteria
You must be 18 or older, and you have to be diagnosed with major depressive disorder (although studies are being made to assess if Spravato can safely treat anxiety and other mental health conditions as well). Treatment resistance means you’ve tried at least two antidepressants at adequate doses for 6-8 weeks each without improvement.
Marpa Minds evaluates your complete clinical picture, including symptom severity and how depression affects your daily life.
Importance of professional evaluation
A thorough psychiatric evaluation determines if Spravato is right for you. This goes beyond basic depression screening.
Providers review your medical history, current medications, and any conditions that might make esketamine unsafe. They also assess your support system and ability to follow treatment requirements.
Frequently Overlooked Benefits of Spravato Treatment
Beyond low addiction risk, Spravato offers advantages that enhance your overall treatment experience and success.
Complementing existing medications
Spravato works alongside your current antidepressant rather than replacing it. This lets you keep any benefits from existing treatments while adding a new approach.
Combination therapy often produces superior results compared to switching medications entirely.
Potential for quick symptom relief
The rapid onset distinguishes Spravato from traditional antidepressants. Many patients experience improvement within days or weeks.
Early improvements in mood or energy help you engage more effectively with therapy and recovery activities.
Positive clinic environment
Receiving treatment in a comfortable, spa-like setting reduces anxiety and promotes healing. Marpa Minds creates an atmosphere that feels therapeutic rather than clinical.
The welcoming environment makes your two-hour monitoring period pleasant and reinforces the treatment’s therapeutic nature.
A Path Forward for Hopeful Relief
Spravato represents a breakthrough for treatment-resistant depression, offering hope when traditional approaches haven’t worked. Low addiction risk and comprehensive safety protocols make it a viable option.
Success depends on proper patient selection, professional administration, and comprehensive care coordination.
Ready To Explore Spravato at Marpa Minds
Marpa Minds provides Spravato therapy in a supportive, spa-like environment designed for healing. Our team handles insurance coordination and administrative tasks so you can focus on recovery.
Our certified facility meets all safety requirements while creating a welcoming atmosphere that reduces treatment anxiety.
Next Steps To Begin Your Treatment Journey
If you’re struggling with treatment-resistant depression, start with a comprehensive evaluation to determine if Spravato might help. Our assessment process is thorough yet supportive.
Take our brief assessment to learn if Spravato could be right for you.
FAQs
Does Spravato cause withdrawal symptoms?
Spravato doesn’t typically cause withdrawal symptoms when you stop treatment under medical supervision. Unlike drugs that cause physical dependence, you can discontinue esketamine without uncomfortable withdrawal or major side effects.
How long do patients typically stay on Spravato therapy?
Treatment duration varies by individual — some patients see benefits after the 4-week induction phase while others continue maintenance therapy for months. Your psychiatrist works with you to determine the optimal length based on your response.
Is esketamine addictive for patients with anxiety or PTSD?
Esketamine shows the same low addiction risk for patients with anxiety or PTSD as for those with depression alone. The supervised clinical setting ensures safe use regardless of other mental health conditions.
Can patients safely transition off Spravato treatment?
You can safely stop Spravato under medical guidance without withdrawal or rebound effects. Your provider creates a personalized plan for transitioning off treatment when appropriate.
How soon after a Spravato session can patients drive?
You cannot drive for at least 24 hours after each Spravato session due to potential sedation effects. Clinics require you to arrange alternative transportation home after treatment.
What happens if someone misses a scheduled Spravato appointment?
Missing an appointment may affect your progress, but it doesn’t cause withdrawal. Your provider helps reschedule and adjust your treatment plan to maintain benefits.
About Author
